PTGX - Protagonist Therapeutics, Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - PTGX (1377121)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
21 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-12-03
PTGXGiraudo BryanDirP - Purchase$5.70+8,00018,000+80%+$45,620
2019-12-03
PTGXGupta SuneelEVP Clinical OperationsP - Purchase$5.13+30,00049,500+154%+$153,900
2019-12-03
PTGXKalkofen Donald A.CFOP - Purchase$5.10+1,1751,175New+$5,987
2019-12-03
PTGXPatel Dinesh V Ph DPres, CEOP - Purchase$5.62+30,000409,824+8%+$168,500
2019-08-06
PTGXLiu David YChief Scientific OfficerS - Sale$8.85-3,39549,802-6%-$30,044
2019-08-06
PTGXPatel Dinesh V Ph DPres, CEOS - Sale$8.85-10,792374,792-3%-$95,535
D
2019-03-01
PTGXLiu David YChief Scientific OfficerS - Sale+OE$8.03-81051,197-2%-$6,504
D
2019-03-01
PTGXPatel Dinesh V Ph DPres, CEOS - Sale+OE$8.03-2,183383,831-1%-$17,529
D
2019-03-01
PTGXShames Richard S.Chief Medical OfficerS - Sale+OE$8.03-65732,021-2%-$5,276
2019-02-06
PTGXPatel Dinesh V Ph DPres, CEOS - Sale$7.74-10,909357,264-3%-$84,410
2019-02-06
PTGXLiu David YChief Scientific OfficerS - Sale$7.74-3,82137,007-9%-$29,562
2019-02-06
PTGXShames Richard S.Chief Medical OfficerS - Sale$7.74-2,77824,178-10%-$21,506
2018-05-17
PTGXCanaan X L.P.10%S - Sale$6.09-38,9682,116,552-2%-$237,358
D
2017-05-16
PTGXGiraudo BryanDirP - Purchase$6.46+10,00010,000New+$64,566
M
2018-05-14
PTGXCanaan X L.P.10%S - Sale$6.42-164,7472,155,520-7%-$1,058,375
2018-03-23
PTGXCanaan X L.P.10%S - Sale$20.71-59,9502,320,267-3%-$1,241,325
M
2018-03-20
PTGXCanaan X L.P.10%S - Sale$20.61-39,5182,380,217-2%-$814,398
M
2018-03-16
PTGXCanaan X L.P.10%S - Sale$20.55-20,3652,419,735-1%-$418,508
M
2018-03-13
PTGXCanaan X L.P.10%S - Sale$20.66-13,1552,440,100-1%-$271,768
D
2018-03-12
PTGXLiu David YChief Scientific OfficerS - Sale+OE$21.29-3,50015,028-19%-$74,500
D
2018-03-02
PTGXLiu David YChief Scientific OfficerS - Sale+OE$20.00-87513,322-6%-$17,500
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top